drugset / Trial / NCT03559868

Inhibition of Sterile Inflammation by Digoxin

NCT03559868

Non-randomizedParallel-groupSingle-blindBasic science

Summary

To investigate the effect of digoxin on pyruvate kinase isoform 2 (PKM2) binding to pro-inflammatory loci and innate immune inflammatory responses in the peripheral blood in healthy subjects.

Timeline

Start
2021-03-01
Primary completion
2023-05-05
Completion
2023-05-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Digoxin Other / unclassified 0.15 ug/kg Oral
Comparator Digoxin Other / unclassified 3 ug/kg Oral

Indications